Give a warm welcome to our new MENA General Manager, Dr. Tamer AbouTaleb!
IGHS Group is strengthening its presence in the Middle East and North Africa markets, this time through its subsidiary INNOV-CELL THERAPEUTICS, which is exclusively focused on the development of innovative biotechnological-based therapeutic solutions in collaboration with several pharmaceutical companies, academic institutions and research & development centers.
Therefore, we are glad to announce that the IGHS Team has been recently joined by Dr. Tamer AbouTaleb, our new MENA General Manager, with more than 22 years of experience in successfully leading, establishing and managing business operations in the Pharmaceuticals, Diagnostics, Consumables, Medical Equipment, Manufacturing and Healthcare domains.
Among several other key positions, Dr. Tamer AbouTaleb was General Manager of United Medical Supplies (UNIMED), Almulla Group – one of the Middle East’s leading healthcare companies, for more than 10 years, and Former Executive Director-Sales at the well-known Al Baker Group. In addition, he has also served in a number of other leading and managerial roles in multinational pharmaceutical companies like GSK, and Schering-Plough.
This relationship plays a key role in the business development of company projects and the strengthening of our market position in the MENA region!
Welcome to the IGHS Team!
New Partnership with REGEnLIFE
The director’s board of REGEnLIFE met yesterday in Paris with the Chairman of IGHS Group, Dr. José Alexandre Cunha and the Commercial Counsellor António Sousa to develop...Read more
The IGHS Group continues its demand for recognition of its work carried out across borders.
Due to the high standards of quality at both technical and human levels that characterise the projects in which the IGHS is involved, an invitation by the Ministry of Health of Uzbekistan to participate in meetings was extended to our group.Read more